Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-17

Clinical Trial Update: Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia [Phase 2, Phase 3]

View source ↗

Summary

A controlled randomized trial comparing ferric carboxymaltose with oral iron for postpartum iron-deficiency anemia was terminated (Phase 2/3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ferric carboxymaltose (ferric carboxymaltose)
  • Oral iron (ferrous sulfate)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Anemia, Iron-Deficiency, Puerperal Disorders | Phase 2, Phase 3 | Status: TERMINATED